Funding Rounds
Enterome Series E (2020, $52M)
EnteromeCutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.
Summary
Stage: Series E
Raised Amount: $52.09M
Raised Date: 2020-01-01
Stage: Series E
Raised Amount: $52.09M
Raised Date: 2020-01-01